ASIA News
It looks to grow its engineering, product, and design teams while expanding across Asia.
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.
The company is looking to expand its coverage across China's Greater Bay Area.
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
It plans to develop an in-house cloud platform.
Its fresh funds will support its product development and international expansion efforts.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Its web-based platform also guides patients to access appropriate medical care.
It plans to expand its coverage in the domestic market.
![[Left] Anjan Bhojarajan, HealthifyMe Chief Business Officer, and [Right] Tushar Vashisht, HealthifyMe CEO](/sites/mhn/files/styles/230x130/public/2025-07/Anjan%2520%2526%2520Tushar-min.jpg?itok=uS4ALdjo)
It provides personalised nutrition and fitness strategies and smart nudges.